Literature DB >> 12677441

Interferon regulatory factor-1 immunoreactivity in neurons and inflammatory cells following ischemic stroke in rodents and humans.

Mihaela Alexander1, Colleen Forster, Koreaki Sugimoto, H Brent Clark, Stefanie Vogel, M Elizabeth Ross, Costantino Iadecola.   

Abstract

Interferon regulatory factor-1 (IRF-1), a transcription factor that controls the expression of genes related to inflammation and injury, may be involved in the mechanisms of cerebral ischemia. In this study, we used immunohistochemistry to determine whether IRF-1 protein is up-regulated after cerebral ischemia, and to define the identity of the cells that express IRF-1 in the postischemic brain. In mice, IRF-1 immunoreactivity was present in intravascular neutrophils 24 h after middle cerebral artery occlusion. At 96 h, immunoreactivity was observed in neutrophils infiltrating the ischemic tissue and in neurons at the outer border of the ischemic territory. IRF-1 immunoreactivity was also found in neurons and inflammatory cells in the brain of patients who died 1-2 days after ischemic stroke. The neuronal expression of IRF-1, in conjunction with the finding that IRF-1 deletion is beneficial to the post-ischemic brain, suggests that expression of IRF-1-dependent genes in neurons plays a role in ischemic neuronal death.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12677441     DOI: 10.1007/s00401-002-0658-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  17 in total

Review 1.  Regulation of microglial activation in stroke.

Authors:  Shou-Cai Zhao; Ling-Song Ma; Zhao-Hu Chu; Heng Xu; Wen-Qian Wu; Fudong Liu
Journal:  Acta Pharmacol Sin       Date:  2017-03-06       Impact factor: 6.150

2.  UBE3A regulates the transcription of IRF, an antiviral immunity.

Authors:  Ryohei Furumai; Kota Tamada; Xiaoxi Liu; Toru Takumi
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

Review 3.  The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.

Authors:  Xiao-Jing Zhang; Ding-Sheng Jiang; Hongliang Li
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

4.  Knockdown of IRF6 Attenuates Hydrogen Dioxide-Induced Oxidative Stress via Inhibiting Mitochondrial Dysfunction in HT22 Cells.

Authors:  Xiao-Min Guo; Bo Chen; Jian-Meng Lv; Qi Lei; Ya-Juan Pan; Qian Yang
Journal:  Cell Mol Neurobiol       Date:  2015-11-30       Impact factor: 5.046

5.  Down-Regulation of IRF6 Protects Cortical Neurons Against Traumatic Neuronal Injury Through Activating Akt-eNOS Pathway.

Authors:  Ming-Shan Hou; Jie Cao; Bo Chen; Xiao-Bin Liu
Journal:  Cell Mol Neurobiol       Date:  2016-06-15       Impact factor: 5.046

6.  Altered expression of PIWI RNA in the rat brain after transient focal ischemia.

Authors:  Ashutosh Dharap; Venkata Prasuja Nakka; Raghu Vemuganti
Journal:  Stroke       Date:  2011-02-10       Impact factor: 7.914

7.  Upregulation of Interferon Regulatory Factor 6 Promotes Neuronal Apoptosis After Traumatic Brain Injury in Adult Rats.

Authors:  Yuchang Lin; Dezhi Xu; Xiaohong Li; Chun Liu; Xia Liu; Shen Huang; Yuwei Huang; Xiaojuan Liu
Journal:  Cell Mol Neurobiol       Date:  2015-06-16       Impact factor: 5.046

8.  Poliovirus type 1 infection of murine PRNP-knockout neuronal cells.

Authors:  Andreina Baj; Alessia Bettaccini; Takuya Nishimura; Takashi Onodera; Antonio Toniolo
Journal:  J Neurovirol       Date:  2005-07       Impact factor: 2.643

9.  Microarray analyses of genes regulated by isoflurane anesthesia in vivo: a novel approach to identifying potential preconditioning mechanisms.

Authors:  Scott D Edmands; Eva Ladow; Adam C Hall
Journal:  Anesth Analg       Date:  2013-02-11       Impact factor: 5.108

Review 10.  Peroxisome Proliferator-Activated Receptor-Gamma (PPAR-ɣ): Molecular Effects and Its Importance as a Novel Therapeutic Target for Cerebral Ischemic Injury.

Authors:  Ashi Mannan; Nikhil Garg; Thakur Gurjeet Singh; Harmeet Kaur Kang
Journal:  Neurochem Res       Date:  2021-07-20       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.